Login to Your Account



Pharmas Add $42M in Merus’ Series B Extension Round

By Marie Powers
Staff Writer

Wednesday, October 9, 2013
Merus BV enticed Johnson & Johnson Development Corp. (JJDC) to join existing investors Novartis Venture Fund and Pfizer Venture Investments for a big pharma trifecta in a €31 million (US$42 million) extension to its Series B financing.

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription